Aeolus Pharmaceuticals Inc (OTCQB:AOLS)

0.25
Data as of Dec 19
 0.00 / 0.00%
Today’s Change
0.19
Today|||52-Week Range
0.55
+8.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$33.6M

Company Description

Aeolus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development of medical countermeasures against biological, chemical, and radiological weapons in the United States. It also develops medical countermeasures for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. The company primarily develops AEOL 10150, a phase I clinical trial lead product for various indications, such as a medical countermeasure against the effects of acute radiation syndrome in the lungs and gastro-intestinal tract, and as a medical countermeasure against the effects of chlorine gas. Aeolus Pharmaceuticals was founded by Brian J. Day in 1994 and is headquartered in Mission Viejo, CA.

Contact Information

Aeolus Pharmaceuticals, Inc.
26361 Crown Valley Parkway
Mission Viejo California 92691
P:(949) 481-9825
Investor Relations:

Employees

Shareholders

Individual stakeholders91.38%
Mutual fund holders--
Other institutional--

Top Executives

David C. CavalierChairman, Chief Financial Officer & Secretary
John L. McManusPresident & Chief Executive Officer
Christopher StanleyVice President-Operations
Brian J. DayChief Scientific Officer
Cindy CroissantDirector-Clinical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.